ArticleTranslational psychiatry2026
Paving the way for precision treatment of psychiatric symptoms with functional connectivity neurofeedback.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Treatment for Major Depressive Disorder (MDD) remains relatively homogeneous, despite patients having heterogeneous subsets of symptoms with differing underlying neural aberrations. Demonstrating potential for a more individualised treatment approach, we recently showed that normalisation of a neural network and a corresponding reduction in related symptoms can be achieved using real-time fMRI functional connectivity neurofeedback (FCNef). Specifically, we showed that brooding rumination but not anxiety symptoms decreased as functional connectivity between the dorsolateral prefrontal cortex (DLPFC) and posterior cingulate cortex/precuneus (PCC) normalised with FCNef. However, the robustness of this effect, how localised it is in the brain, and the best parameters for optimising therapeutic outcomes remained unknown. We therefore ran additional participants (final N = 68) in our FCNef protocol. We replicated our original findings and ran new analyses that better highlighted the precision of this effect to rumination symptoms. For the first time we also demonstrated that connectivity between the Executive Control and Default-Mode networks reduced significantly with FCNef. Finally, we manipulated core FCNef parameters between participants and found that the most effective protocol involved consecutive training days with greater external reward. These results highlight the potential of FCNef for precision medicine in psychiatry and underscore the importance of optimising parameters to enhance feasibility of BMI-based clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.